Header Logo

Connection

Afaaf Liberty to Drug Resistance, Viral

Back to Details
This is a "connection" page, showing publications Afaaf Liberty has written about Drug Resistance, Viral.
Afaaf Liberty
Connection Strength
0,210
Drug Resistance, Viral
  1. Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet HIV. 2025 Mar; 12(3):e201-e213.
    View in: PubMed
    Score: 0,210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.